SJRNF yields 1818.18% · JNJ yields 2.13%● Live data
📍 SJRNF pulled ahead of the other in Year 1
Combined, SJRNF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SJRNF + JNJ for your $10,000?
ArcWest Exploration Inc. engages in the exploration of mineral properties in Canada. It primarily explores for copper and gold deposits. The company holds 100% interests in the Todd Creek property located in northeast of Stewart; the Oweegee Dome property that covers an area of 31,077 hectares located in east of Tudor Gold's Treaty Creek; the Oxide Peak property, which covers an area of 8,438 hectares located in the Toodoggone District; the Teeta Creek property located in northern Vancouver Island, British Columbia; and the Northern Vancouver Island property that covers an area of 6,884 hectares located in northern Vancouver. It also has interests in the Rip property, which covers an area of 7,811 hectares situated in south of Houston; Sparrowhawk project that covers an area of 9,913 hectares located in southeast of the Morrison Cu deposit; and the Eagle property covering an area of 2,530 hectares located in in northern Vancouver Island, British Columbia. The company was formerly known as Sojourn Exploration Inc. and changed its name to ArcWest Exploration Inc. in February 2019. ArcWest Exploration Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.
Full SJRNF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.